Protective effect of Chinese herbs for supplementing qi, nourishing yin and activating blood circulation on heart function of patients with acute coronary syndrome after percutaneous coronary intervention

Chinese Journal of Integrative Medicine

Volumn 18, Issue 6, 2012, Pages 423-430

  Liu, Hong Ying ^a,b   Wang, Wei ^b   Shi, Da Zhuo ^a   Ge, Jun Bo ^b   Zhang, Lei ^a   Peng, Juan ^b   Wang, Cheng Long ^a   Wang, Pei Li ^a  

^a XIYUAN HOSPITAL   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Nourishing yin and activating blood circulation; Percutaneous coronary intervention; Supplementing qi

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; CLOPIDOGREL; COMPOUND CHUANXIONG CAPSULE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; NITRIC ACID DERIVATIVE; UNCLASSIFIED DRUG; XINYUE CAPSULE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD SAMPLING; BLOOD STASIS SYNDROME SCORE; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHINESE MEDICINE; CHINESE MEDICINE SYMPTOM SCORE; CIRCULATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPH; FEMALE; FOLLOW UP; HEALTH CARE ORGANIZATION; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE WALL; HEART PROTECTION; HEART VENTRICLE SEPTUM; HEMOSTASIS; HERBAL MEDICINE; HUMAN; INTERVENTRICULAR SEPTAL THICKNESS; LEFT VENTRICULAR POSTERIOR WALL THICKNESS; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; C-REACTIVE PROTEIN; CARDIOTONIC AGENTS; CHINA; CORONARY CIRCULATION; DRUGS, CHINESE HERBAL; FEMALE; HEART FUNCTION TESTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NEW YORK; PEPTIDE FRAGMENTS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; QI; SOCIETIES, MEDICAL; SYNDROME; ULTRASONOGRAPHY; YIN-YANG;

EID: 84867336348     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-012-0966-5     Document Type: Article

References (23)

1. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction- executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44:671-719.
2. Ferrari R, Perindopril and Remodeling in Elderly with Acute Myocardial Infarction Investigators. Effects of angiotensinconverting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study. Arch Intern Med 2006;166:659-666.
3. Su CL, Shen SG. Modern cardiology of Chinese medicine. Beijing: Beijing Science and Technology Press; 1997:61-65.
4. Chinese Society of Cardiology, Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. Diagnosis and treatment recommendations of unstable angina. Chin J Cardiol (Chin) 2000;28:409-412.
5. Chinese Society of Cardiology, Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology, Editorial Board of Chinese Journal of Circulation. Diagnosis and treatment recommendations of acute myocardial infarction. Chin J Cardiol (Chin) 2001;29:705-720.
6. Committee of Cardiovascular Disease, Chinese Association of Integrated Traditional Chinese and Western Medicine. Standard of syndrome differentiation of coronary heart disease in Chinese medicine. Chin J Integr Tradit West Med (Chin) 1991;11:257.
7. Wang J, Chen KJ, Weng WL, Qian ZH, Wang Y, Liu JG, et al. Research on the diagnostic criteria of blood-stasis symptom-complex. Chin J Integr Tradit West Med (Chin) 1988;10:580-585.
8. Chen ZJ, Gao RL, eds. Studies on clinical coronary heart disease. Beijing: People's Medical Publishing House; 2002:381-405.
9. Wang XF, ed. Ultrasound echocardiography. Beijing: People's Medical Publishing House; 2002:456-458.
10. Eigenbaum H, ed. Echocardiography. 4th ed. Philadelphia: Lea and Febiger; 1986:462-513.
11. Møller JE, Hillis GS, Oh JK, Reeder GS, Gersh BJ, Pellikka PA. Wall motion score index and ejection fraction for risk stratification after acute myocardial infarction. Am Heart J 2006;151:419-425.
12. Shereif H R, Robert AK. No-reflow phenomenon. Circulation 2002;105:656-662.
13. Gong X, Yang J, Fang YM. No-reflow phenomenon following reperfusion in acute myocardial infarction. Medical Recapit (Chin) 2006;12:480-482.
14. Dzavík V, Buller CE, Lamas GA, Rankin JM, Mancini GB, Cantor WJ, et al. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial. Circulation 2006;114:2449-2457.
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
16. Ranjith N, Pegoraro RJ, Naidoo DP, Kaloo AS, Esterhuizen TM. The role of echocardiography and its comparison with NT-proBNP measurements in patients with acute myocardial infarction. Med Sci Monit 2007;13:CR574- CR578.
17. Biagini E, Galema TW, Schinkel AF, Vletter WB, Roelandt JR, Ten Cate FJ. Myocardial wall thickness predicts recovery of contractile function after primary coronary intervention for acute myocardial infarction. J Am Coll Cardiol 2004;43:1489-1493.
18. Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, et al. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy. J Hypertens 2006;24:1531-1539.
19. Jernberg T, Stridsberg M, Venge P, Lindahl B. N-terminal probrain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002; 40:437-445.
20. FRISC-II Study Group. Invasive compared with noninvasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during Instability in Coronary Artery Disease Investigators. Lancet 1999;354:708-715.
21. Abbate A, Biondi-Zoccai GG, Brugaletta S, Liuzzo G, Biasucci LM. C-reactive protein and other inflammatory biomarkers as predictors of outcome following acute coronary syndromes. Semin Vasc Med 2003;3:375-384.
22. He LP, Tang XY, Ling WH, Chen WQ, Chen YM. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies. Heart 2010;96:339-346.
23. Li YQ, Jin M, Qiu SL, Wang PL, Zhu TG, Wang CL, et al. Effect of Chinese drugs for supplementing qi, nourishing yin and activating blood circulation on myocardial perfusion in patients with acute myocardial infarction after revascularization. Chin J Integr Med 2009;15:19-25.